Published in Oncol Lett on November 23, 2016
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst (1990) 13.41
Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov (2007) 11.46
Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem (1993) 5.09
Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res (1995) 4.55
Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) (1998) 4.31
Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res (2007) 3.64
Management of non-small-cell lung cancer: recent developments. Lancet (2013) 3.51
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer (1996) 3.07
Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer (2005) 2.12
Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol (1998) 1.96
Biology of hepatocellular carcinoma. Ann Surg Oncol (2008) 1.78
Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol (2010) 1.49
How oxygen makes its presence felt. Genes Dev (2002) 1.45
High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential. Hepatology (2000) 1.32
Angiogenesis in multiple myeloma. Eur J Cancer (2006) 1.31
Effects of corticosteroid use on treatment of solid tumours. Lancet (2002) 1.21
Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. J Orthop Res (2004) 1.20
Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology (2008) 1.17
High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression. Lung Cancer (2001) 1.06
Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia. Int J Oncol (2008) 1.06
Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer. Eur J Cancer (2000) 1.01
Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Cancer Res (2008) 0.99
Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol Appl Neurobiol (1999) 0.99
Expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma. Dis Markers (2008) 0.97
A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma. PLoS One (2012) 0.93
Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer. Lung Cancer (2001) 0.91
Dual functions of DNA replication forks in checkpoint signaling and PCNA ubiquitination. Cell Cycle (2009) 0.91
Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics. Int J Oncol (2007) 0.90
A new family of angiogenic factors. Cancer Lett (2005) 0.89
Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer. Arch Med Res (2007) 0.84
Useful detection of CD147 (EMMPRIN) for pathological diagnosis of early hepatocellular carcinoma in needle biopsy samples. World J Gastroenterol (2007) 0.84
Enhancement by dexamethasone of the therapeutic benefits of cisplatin via regulation of tumor angiogenesis and cell cycle kinetics in a murine tumor paradigm. Toxicology (2006) 0.81
Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran. World J Gastroenterol (2007) 0.80
[Expression and significance of PCNA and Caspase-3 in the tissue of lung cancer]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2010) 0.77
Clinical implications of serum hypoxia inducible factor-1α and vascular endothelial growth factor in lung cancer. Tumori (2015) 0.77
Treatment of esophageal-gastric double primary cancer by pedunculated remnant gastric interposition, esophageal-gastric anastomosis and gastrojejunal Billroth II anastomosis: A case report. Oncol Lett (2015) 0.75
Synchronous double primary cancer of the lung and nasal vestibule: A case report and literature review. Mol Clin Oncol (2016) 0.75
B-cell specific Moloney leukemia virus insert site 1 and peptidyl arginine deiminase IV positively regulate carcinogenesis and progression of esophageal squamous cell carcinoma. Oncol Lett (2017) 0.75